curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Polygenic Embryo Selection

by palligoelme@gmail.com | Sep 25, 2026 | Clinical Trials

​ Conditions: Polygenic Score Sponsors: Nucleus Genomics Inc. Not yet recruiting Conditions: Polygenic Score Sponsors: Nucleus Genomics Inc. Not yet recruiting 

A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty Arthritis

by palligoelme@gmail.com | Sep 25, 2026 | Clinical Trials

​ Conditions: Acute Gouty Arthritis Interventions: Drug: Compound Betamenth Group; Drug: IBI3011 GROUP Sponsors: Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting Conditions: Acute Gouty Arthritis Interventions: Drug: Compound Betamenth Group; Drug: IBI3011...

Real-World Effectiveness and Costs of Yiqi Fumai Lyophilized Injection in Coronary Heart Disease-Related Chronic Heart Failure

by palligoelme@gmail.com | Sep 25, 2026 | Clinical Trials

​ Conditions: Chronic Heart Failure; Coronary Heart Disease (CHD) Interventions: Drug: Yiqi Fumai Lyophilized Injection Sponsors: China Academy of Chinese Medical Sciences Not yet recruiting Conditions: Chronic Heart Failure; Coronary Heart Disease (CHD)...

New CBC Parameters in Diagnosis of Hereditary Spherocytosis

by palligoelme@gmail.com | Sep 25, 2026 | Clinical Trials

​ Conditions: Hereditary Spherocytosis; Hemolytic Anemia Sponsors: Assiut University Not yet recruiting Conditions: Hereditary Spherocytosis; Hemolytic Anemia Sponsors: Assiut University Not yet recruiting 

Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases.

by palligoelme@gmail.com | Sep 25, 2026 | Clinical Trials

​ Conditions: Lung Cancer (Non-Small Cell); Radiation; Brain Injury; Brain Edema; Brain Necrosis Interventions: Drug: Recombinant Human Endostatin (Endostar); Drug: Recombinant Human Endostatin (Endostar) Sponsors: Jiangmen Central Hospital Not yet...

Cohort Study on the Levels of Placental Growth Factor and Nucleosomes in Early Pregnancy and Adverse Pregnancy Outcomes

by palligoelme@gmail.com | Sep 25, 2026 | Clinical Trials

​ Conditions: Preeclampsia; Premature Birth; Fetal Growth Restriction; Recurrent Miscarriage Interventions: Other: Measurement of plasma nucleosome and placental growth factor (PLGF) levels Sponsors: Second Affiliated Hospital of Wenzhou Medical University Not yet...
« Older Entries
Next Entries »

Recent Posts

  • GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
  • Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
  • ABVN Phase 2 – Vagal Maneuvers
  • A Test of Acceptance-based Bibliotherapy for Hoarding Disorder
  • Semaglutide for the Treatment of Cannabis Use Disorder

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®